Oct 30 (Reuters) - Sigma Healthcare Ltd SIG.AX
* Sigma's guidance for FY2018 and FY2019 is unchanged
* Astra Zeneca asdvised they intend to exclusively distribute proportion of their products direct to pharmacy
* Co reviewing options to offset earnings impact of Astra Zeneca announcement